BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31341975)

  • 1. Individual lymph nodes: "See it and Zap it".
    Winkel D; Werensteijn-Honingh AM; Kroon PS; Eppinga WSC; Bol GH; Intven MPW; de Boer HCJ; Snoeren LMW; Hes J; Raaymakers BW; Jürgenliemk-Schulz IM
    Clin Transl Radiat Oncol; 2019 Sep; 18():46-53. PubMed ID: 31341975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target coverage and dose criteria based evaluation of the first clinical 1.5T MR-linac SBRT treatments of lymph node oligometastases compared with conventional CBCT-linac treatment.
    Winkel D; Bol GH; Werensteijn-Honingh AM; Intven MPW; Eppinga WSC; Hes J; Snoeren LMW; Sikkes GG; Gadellaa-van Hooijdonk CGM; Raaymakers BW; Jürgenliemk-Schulz IM; Kroon PS
    Radiother Oncol; 2020 May; 146():118-125. PubMed ID: 32146257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a vacuum cushion on intrafraction motion during online adaptive MR-guided SBRT for pelvic and para-aortic lymph node oligometastases.
    Werensteijn-Honingh AM; Jürgenliemk-Schulz IM; Gadellaa-Van Hooijdonk CG; Sikkes GG; Vissers NGPM; Winkel D; Eppinga WSC; Intven M; Raaymakers BW; Kroon PS
    Radiother Oncol; 2021 Jan; 154():110-117. PubMed ID: 32950531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric feasibility of hypofractionation for SBRT treatment of lymph node oligometastases on the 1.5T MR-linac.
    Winkel D; Werensteijn-Honingh AM; Eppinga WSC; Intven MPW; Hes J; Snoeren LMW; Visser SA; Bol GH; Raaymakers BW; Jürgenliemk-Schulz IM; Kroon PS
    Radiother Oncol; 2021 Jan; 154():243-248. PubMed ID: 32949691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simulated dosimetric impact of online replanning for stereotactic body radiation therapy of lymph node oligometastases on the 1.5T MR-linac.
    Winkel D; Kroon PS; Werensteijn-Honingh AM; Bol GH; Raaymakers BW; Jürgenliemk-Schulz IM
    Acta Oncol; 2018 Dec; 57(12):1705-1712. PubMed ID: 30280631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors.
    Padgett KR; Simpson GN; Llorente R; Samuels MA; Dogan N
    Cureus; 2018 Apr; 10(4):e2423. PubMed ID: 29872603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing adaptation strategies in MRI-guided online adaptive radiotherapy for prostate cancer: Implications for treatment margins.
    Dassen MG; Janssen T; Kusters M; Pos F; Kerkmeijer LGW; van der Heide UA; van der Bijl E
    Radiother Oncol; 2023 Sep; 186():109761. PubMed ID: 37348607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-fraction motion of pelvic oligometastases and feasibility of PTV margin reduction using MRI guided adaptive radiotherapy.
    Snyder J; Smith B; St-Aubin J; Dunkerley D; Shepard A; Caster J; Hyer D
    Front Oncol; 2023; 13():1098593. PubMed ID: 37152034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of magnetic resonance-guided versus conventional radiotherapy workflows on organ at risk doses in stereotactic body radiotherapy for lymph node oligometastases.
    Werensteijn-Honingh AM; Kroon PS; Winkel D; van Gaal JC; Hes J; Snoeren LMW; Timmer JK; Mout CCP; Bol GH; Kotte AN; Eppinga WSC; Intven M; Raaymakers BW; Jürgenliemk-Schulz IM
    Phys Imaging Radiat Oncol; 2022 Jul; 23():66-73. PubMed ID: 35814260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitigation on bowel loops daily variations by 1.5-T MR-guided daily-adaptive SBRT for abdomino-pelvic lymph-nodal oligometastases.
    Cuccia F; Rigo M; Gurrera D; Nicosia L; Mazzola R; Figlia V; Giaj-Levra N; Ricchetti F; Attinà G; Pastorello E; De Simone A; Naccarato S; Sicignano G; Ruggieri R; Alongi F
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3269-3277. PubMed ID: 34268583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of plan adaptation strategies for stereotactic radiotherapy of lymph node oligometastases using online magnetic resonance image guidance.
    Winkel D; Bol GH; Werensteijn-Honingh AM; Kiekebosch IH; van Asselen B; Intven MPW; Eppinga WSC; Raaymakers BW; Jürgenliemk-Schulz IM; Kroon PS
    Phys Imaging Radiat Oncol; 2019 Jan; 9():58-64. PubMed ID: 33458426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Online Adaptive MRI-Guided Radiotherapy for Primary Tumor and Lymph Node Boosting in Rectal Cancer.
    Kensen CM; Betgen A; Wiersema L; Peters FP; Kayembe MT; Marijnen CAM; van der Heide UA; Janssen TM
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experience.
    Paulson ES; Ahunbay E; Chen X; Mickevicius NJ; Chen GP; Schultz C; Erickson B; Straza M; Hall WA; Li XA
    Clin Transl Radiat Oncol; 2020 Jul; 23():72-79. PubMed ID: 32490218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ITV versus mid-ventilation for treatment planning in lung SBRT: a comparison of target coverage and PTV adequacy by using in-treatment 4D cone beam CT.
    Bellec J; Arab-Ceschia F; Castelli J; Lafond C; Chajon E
    Radiat Oncol; 2020 Mar; 15(1):54. PubMed ID: 32127010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards mid-position based Stereotactic Body Radiation Therapy using online magnetic resonance imaging guidance for central lung tumours.
    Ligtenberg H; Hackett SL; Merckel LG; Snoeren L; Kontaxis C; Zachiu C; Bol GH; Verhoeff JJC; Fast MF
    Phys Imaging Radiat Oncol; 2022 Jul; 23():24-31. PubMed ID: 35923896
    [No Abstract]   [Full Text] [Related]  

  • 16. Dosimetric benefit of MR-guided online adaptive radiotherapy in different tumor entities: liver, lung, abdominal lymph nodes, pancreas and prostate.
    Nierer L; Eze C; da Silva Mendes V; Braun J; Thum P; von Bestenbostel R; Kurz C; Landry G; Reiner M; Niyazi M; Belka C; Corradini S
    Radiat Oncol; 2022 Mar; 17(1):53. PubMed ID: 35279185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: clinical implementation and initial experience.
    Intven MPW; de Mol van Otterloo SR; Mook S; Doornaert PAH; de Groot-van Breugel EN; Sikkes GG; Willemsen-Bosman ME; van Zijp HM; Tijssen RHN
    Radiother Oncol; 2021 Jan; 154():172-178. PubMed ID: 32976875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
    Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
    Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating the impact of patient arm position in an MR-linac on liver SBRT treatment plans.
    van den Wollenberg W; de Ruiter P; Nowee ME; Jansen EPM; Sonke JJ; Fast MF
    Med Phys; 2019 Nov; 46(11):5144-5151. PubMed ID: 31529694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic lymph node motion during cone-beam computed tomography guided stereotactic radiotherapy.
    Janssen J; Staal FHE; Langendijk JA; Both S; Brouwer CL; Aluwini S
    Clin Transl Radiat Oncol; 2024 Jul; 47():100794. PubMed ID: 38798748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.